BMY-42568

N/A

Report date: 2023/02/18 16:53:01
NME

Base Information

Drug NameBMY-42568
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin reuptake inhibitors
TargetsSerotonin 1a (5-HT1a) receptorSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A